Summary
Updated Aug 31, 2026
Brian M. Strem is President and CEO, Director of KIORA PHARMACEUTICALS INC (KPRX). 4 SEC Form 4 filings on record, most recently on 2 July 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Brian M. Strem has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Brian M. Strem's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- KKR Phoenix Aggregator L.P. - $2.09B of BTSG open-market activity in the last 12 months
- KKR Group Partnership L.P. - $2.09B of BTSG open-market activity in the last 12 months
- WARBURG PINCUS CO. - $1.30B of SHC open-market activity in the last 12 months
- GTCR INVESTMENT XI LLC - $760.39M of SHC open-market activity in the last 12 months
- Martine A. Rothblatt - $703.37M of UTHR open-market activity in the last 12 months
- Ronda E. Stryker - $580.89M of SYK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Brian M. Strem?
Brian M. Strem is a corporate insider, tracked as President and CEO, Director of KIORA PHARMACEUTICALS INC (KPRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian M. Strem submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Brian M. Strem's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Brian M. Strem and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
